United Therapeutics (UTHR) Approves $100M Buyback
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Join SI Premium – FREE
United Therapeutics Corporation (Nasdaq: UTHR) approves a new $100 million share repurchase program.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Spotify expands share buyback program by $1.5 billion
- Cosmos Health posts 29% revenue rise in Q2 but net loss widens
- United States Antimony approves $100M share buyback program
Create E-mail Alert Related Categories
Stock BuybacksRelated Entities
Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
